WorkflowRegulatory Affairs

Post-Marketing Commitment Tracking

Post-marketing commitment tracking that catches the promises made outside approval letters

See one case, screen by screen ↓

Built forRegulatory leadsRegulatory operationsEU regulatory leadsFunctional ownersCompliance officers

The Problem Today

Approval letters are typed into a tracker by hand, and promises in meeting minutes are often not tracked at all.

38 h
to compile one annual status table by hand our estimate

Promises scattered across

  • Letters
  • Minutes
  • Responses
  • Tracker
  • Slips seen only at year endFound when the annual report lists them as Delayed
  • Inherited, with no ownerCommitments from an acquisition arrive with nobody on them

The Solution

  1. Each letter readEach requirement, commitment and promise, with its dates and its page
  2. Hidden promises foundMinutes re-read, discussion included, for promises nobody tracked
  3. Owners alerted well aheadAlerts at set lead times; a missed internal target raises a slip
  4. The regulatory lead signsEach item found is confirmed, edited or rejected, then signed

Built-in controls

  • Two signatures to move a date
  • Closed only when the agency confirms it
  • The agency's wording, copied exactly

What You Get

A slipping commitment is flagged when its first internal target is missed, months before the agency date.

  • Status tables in 6 hour estimateDrafted from the register, each row cited
  • All markets in one registerUS requirements, EU obligations and local conditions
  • Progress reports drafted tooAccelerated-approval and EU obligation updates, cited
In short

What is Post-Marketing Commitment Tracking?

Keeping every postmarketing requirement and commitment, EU obligation and local approval condition on record with its dates, owners and status until the agency confirms it is fulfilled. Post-Marketing Commitment Tracking does it with agents that read approval letters, minutes and question responses and put each item on one timeline by product, with the agency's exact words and the page.

How to choose AI solutions for life sciences →

Updated

The problem

Post-marketing commitments slip months before the annual report shows it

After approval, a sponsor owes its regulators a long list of things: studies required under 505(o)(3), pediatric studies deferred under PREA, clinical and CMC commitments, 180-day progress reports on an accelerated-approval confirmatory trial, EU specific obligations, Annex II conditions and post-authorisation measures, local approval conditions in Japan, Switzerland, Brazil or Australia. Each sits in a different letter with its own dates. Approval letters get entered into the tracker by hand; minutes and question responses are filed as correspondence.

The promises inside those minutes are entered only if someone notices them. In a Type C meeting the action items list FDA's tasks; the sponsor's dated promise sits three paragraphs up, in the discussion. Internal milestones, such as lots made or patients enrolled, are missed months before the agency date, and nobody sees it until regulatory operations compiles the annual status table and a commitment goes in as Delayed.

estimated38hoursto compile one annual status table by hand, 14 of them gathering status from the functional owners
Where the hours on one annual status table goestimated
By hand38 hours
With the solution6 hours
  • Gathering status from the functional owners14 → 2 h
  • Cross-checking the register, the archive and the letters12 → 1.5 h
  • Writing the explanation for each requirement and commitment8 → 1.5 h
  • Review and fixes before signature4 → 1 h

Estimated per application, by hand and with the status table drafted from the register: the working solution's own estimate before deployment.

How it works

Commitment tracking from an incoming letter to a signed timeline entry

What comes in
Letters inLetters, minutes, responses · every agency, every market
Agents at work
Correspondence Readeragency, product, date
Then
Commitment Extractorexact words + page
Promise Finderminutes, responses
Then
Change & Duplicate Checkernew or a change
Owner Routerproposes owners
Then
Deadline Monitorevery morning
Then
Status Reportercited drafts
A person decides
Regulatory leadconfirms each date and signs
What comes out
Signed timeline
Alerts from 90 days out
Annual status tables
One case, step by step

Three FDA letters, and the promise in the minutes nobody tracked

A drug maker has four marketed products, one of them inherited in an acquisition, and 29 open items with 8 health authorities. One morning, three new FDA letters are waiting. Here is what happens next, screen by screen, in the working solution.

A worked example on sample data. Names, IDs and figures on the screens and in this section come from the demo.

  1. 01Morning

    All dates owed to agencies, on one timeline

    Regulatory lead

    The lead's home screen is a timeline by product: requirements as circles, commitments and promises as squares, colored at risk, watch, on track or later. The red one is on the company's biologic: a post-marketing commitment to re-evaluate the HMW species limits, due in 24 days, with only 21 of the 30 commercial lots made. The panel shows where the date comes from: the approval letter for the BLA, page 2, in FDA's own words.

    “Every date links to the page it came from.”

  2. 02One click

    “Read 3 new letters”: five steps, in view

    The agents

    The Correspondence Reader classifies a supplement approval for the biologic, a fulfillment letter for a postmarketing requirement on a second product, and Type B minutes for that second product. The Commitment Extractor finds 6 items with their page and exact words and sets a standing reminder aside. The Change & Duplicate Checker sorts them: 4 new, 1 change to an existing commitment, 1 requirement fulfilled.

    “Proposed dates are on the timeline, dashed. Nothing is final until you sign.”

  3. 03Seconds later

    A new pediatric study, its protocol due in nine months

    Commitment Extractor

    The supplement approval for Crohn's disease brings a new PREA requirement, a study in patients 6 to 17 years old: the final protocol in nine months, study completion three years after that and the final report six months later. It lands on the biologic's lane as a dashed, proposed date, with the regulatory lead and the clinical owner as owners. On the second product, two promises from the Type B minutes appear the same way: a revised statistical analysis plan for an ongoing study, by a date set in the minutes, and a pediatric formulation bridging plan with the next annual report.

    “Proposed · waiting for your signature”

  4. 04Because of the new approval

    Promises outside approval letters

    Promise Finder

    The new approval makes the Promise Finder re-read the biologic's 63 minutes and responses on file, discussion included. The panel lists the 5 promises it finds: two Health Canada responses already on the timeline, the two new promises on the second product, and one from a Type C meeting that was never tracked.

    “Never tracked · filed months ago”

  5. 05Page 2, Question 3

    A shipping validation report that sits in nobody's tracker

    Promise Finder

    In the Type C minutes for the biologic's prefilled syringe, the sponsor's promise sits in the discussion of Question 3, not in the action items. The minutes were filed with no timeline entry. The lead sees the exact sentence, the page, the date highlighted and the proposed owners: the lead and the CMC owner.

    The sponsor agreed to submit a shipping validation report for the 200 mg/mL prefilled syringe to the BLA by a fixed date, months away.

  6. 06One signature

    Added with the meaning of the signature

    Regulatory lead

    “Add to the timeline” opens the promise with its due date fixed by the minutes, the CMC owner as functional owner, and the meaning of the signature: “I approve this timeline entry”. The alerts are already scheduled and the minutes stay linked as the source. The Promise Finder only proposes; nothing reaches the timeline without the lead's signature.

    Alerts are scheduled at 90, 60, 30 and 7 days before the due date.

  7. 07Signed

    On the timeline; the CMC owner hears 90 days ahead

    Regulatory lead

    The promise becomes a solid square on the biologic's lane, Pending, with the Type C minutes as its source. The count of open items goes from 29 to 30. The CMC owner is notified as owner, and the signature is on the activity trail.

    “On the timeline · owner notified · alerts set”

  8. 08The supplement letter

    Each item confirmed, edited or rejected, then signed

    Regulatory lead

    The letter opens beside what the agents found, each with its page and confidence: the new PREA requirement at 97%, the change to the long-term remission registry at 94% with the old and new wording side by side, and a new commitment for a drug-tolerant ADA assay. The distribution reporting reminder is set aside as not a commitment. The lead decides each item and signs; the change to the existing commitment also goes to compliance for countersignature.

    “A change to an existing commitment also goes to compliance for countersignature. The original wording stays in the record history.”

  9. 09The one that will slip

    Internal targets missed months before the agency date

    Deadline Monitor

    On the HMW-limits commitment the Deadline Monitor has raised a slip: three internal targets (25 lots released, 30 lots released, the data review) were missed by 99, 37 and 7 days. The 30th lot is not planned until after the agency date, so that date cannot be met. “Request a new date” drafts the reason in the agency's terms; the new date needs the lead's signature and the compliance countersignature.

    “Internal targets from the owner's plan are shown with the agency date. They slip first.”

  10. 1074 days before it is due

    The annual status table, drafted and cited

    Status Reporter · regulatory operations

    The biologic's BLA reaches its approval anniversary in two weeks, so its status report under 21 CFR 601.70 is due 60 days after that. The Status Reporter writes one row for each of the 6 requirements and commitments: original and current schedule, the agency status category and an explanation with its evidence. The HMW-limits commitment goes in as Delayed. Regulatory operations reviews; the lead signs.

    “Every status uses the agency's words; every explanation cites its evidence.”

Who it’s for

The owners of each date: regulatory, operations, EU, CMC and compliance

The same commitments as five owners carry them, first by hand and then from one register.

Regulatory lead
Signs each register entry
Before
Owns 29 open items across 4 products and 8 agencies, and worries less about the requirements in the letters than about what the company said in a meeting months ago.
Now
Sees the dates owed on one timeline, each linked to its page; the promise in the minutes is found and added with one signature.
Regulatory operations specialist
Compiles the status reports
Before
Compiles each annual status table by cross-checking the tracker against the functions: thirty-eight hours per table, half of it chasing people for one sentence.
Now
Reviews a status table drafted from the register, one row per requirement and commitment, each explanation citing its evidence.
EU regulatory lead
Owns EU obligations and renewals
Before
Tracks SOB, ANX, MEA and REC due dates and a conditional renewal, and has seen EMA notice a due date before the team did.
Now
Signs each EU entry and change; EU obligations are routed to the EU lead by rule and sit on the same timeline as the US ones.
CMC owner
Owns stability, assays and shipping validation
Before
Hears about a CMC commitment when it is nearly due, a week out instead of the 90 days needed.
Now
Owns the shipping validation promise from the day it is signed, with alerts at 90, 60, 30 and 7 days and internal targets shown beside the agency date.
Compliance officer
Countersigns date and scope changes
Before
Is asked after the fact why a date moved, and needs to see who changed it, why, and what the agency wrote.
Now
Countersigns each change to a date or scope, with the reason, the agency's wording and the earlier version in the record.
The agents

Letter readers, promise finders and deadline monitors for each PMR and PMC

Letters, minutes and responses are read for every commitment, untracked promises caught, dates watched and reports drafted; the regulatory lead signs.

Correspondence Reader

Reads each incoming letter, set of minutes and response, and works out the agency, document type, product, application and date. Translated copies keep a link to the original.

  • Never discards a page; each page is kept and searchable
  • Unknown document types go to a person
Commitment Extractor

Finds every requirement, commitment, condition and promise (PMRs and PMCs, specific obligations, Annex II conditions, post-authorisation measures, local conditions) with the exact wording, the page, the legal basis and its dates. Standing reminders are marked as not a commitment.

  • Wording is copied exactly, never paraphrased
  • Every item carries its page
  • An item without a date is flagged for a person to set one
Promise Finder

Reads meeting minutes, question responses and emails for what the company said it would do, in the discussion as well as the action items, and checks each against the timeline. When a product receives a new approval, it re-reads that product's minutes and responses on file.

  • Never adds a promise without a signature
  • Quotes the exact words and the page, with no paraphrase
  • A promise without a date is shown as undated, never given one
Change & Duplicate Checker

Matches each found item against the register by number, product, wording and study: new, a change to an existing record, or a status event such as fulfilled or released. Links the same study across markets.

  • Never overwrites a record; proposes the change for signature
  • The original wording and dates are kept in history
Owner Router

Proposes the regulatory owner and the functional owner from the routing rules: clinical studies to the clinical owner, stability and assays to CMC, registries and observational studies to real-world evidence, EU obligations to the EU regulatory lead. Inherited records without a functional owner are raised as a risk.

  • Owners are proposed; a person confirms
Deadline Monitor

Each morning at 06:00 checks the open milestones and internal targets, alerts the owners at the lead times in Settings, raises a slip when an internal target is missed and escalates 30 days out when no draft or evidence exists.

  • Never changes a date
  • An alert always names the record, the date and the owner
Status Reporter

Drafts annual status tables, 180-day progress reports and EU obligation updates from the register: original and current schedule, the agency's status category and a short factual explanation, with citations.

  • Submitted is never written as fulfilled
  • A delayed item carries a reason and a revised date
  • Never submits; a person signs
Regulatory lead

Confirms each date and signs.

Ask in plain words

What the register answers about letters, promises and due dates

Ask in plain words, or tell it what to change. Each answer points to the letter and page it came from. These answers use the sample data.

Did we promise anything in meetings that is not on the timeline?

Yes, one. In earlier Type C minutes for the biologic, page 2, the company agreed to submit a shipping validation report for the 200 mg/mL syringe by a fixed date. It sits in the discussion of Question 3, not the action items, and the minutes were filed a month later with no timeline entry.

Which commitments came with the acquired product?

Four, transferred with the acquisition. Two have no functional owner. The extractables and leachables study is due at year end and has had no status for months.

Draft the biologic's annual status table

The BLA reaches its approval anniversary in two weeks, so the status report is due 60 days later, under 21 CFR 601.70. The Status Reporter writes one row per requirement and commitment with the agency's status words and the evidence. One item will need a decision: the HMW limits re-evaluation cannot meet its date.

Add a rule: alert me 120 days before any EU specific obligation

Done. EU specific obligations now alert 120 days ahead as well as at the usual lead times (90, 60, 30 and 7 days). It applies to 3 open obligations today, two on the conditionally authorized product and one on the acquired product. Alerts go to the EU regulatory lead, and the rule is in Settings and on the audit trail.

The screens

A commitment timeline with dashed proposed dates and the annual status table

From the working solution, on its sample data. Pick one to see it large.

Commitment timelineRequirements, commitments and promises by product at their due dates, colored by risk, with the source of the selected date beside it.
Agents reading new lettersThree new FDA letters classified, six items found with their page and exact words, changes and a fulfillment sorted, the product's minutes re-read.
Proposed dates, dashedNew dates from the letters sit on the timeline as proposals until the regulatory lead signs: here a pediatric requirement, its protocol due in nine months.
Promises outside approval lettersThe promises found in minutes and responses, which are on the timeline, which are new, and the one never tracked.
Where this date comes fromThe never-tracked promise with the minutes, the page, the sentence and the date highlighted, and why it was missed.
Add a promise with a signatureDue date, functional owner, the meaning of the signature and the alerts that will follow.
On the timelineThe promise signed onto the biologic's lane with its source, its owner notified and its alerts set.
Letter reviewThe supplement approval letter beside each item found, with its page, confidence, schedule, owners and the wording change to an existing record.
The registerRequirements, commitments, obligations, conditions and promises with their next milestone, schedule, status and owner, filtered by type, product, agency or due date.
One commitmentThe agency's exact wording, the schedule with internal targets beside the agency date, owners, progress and the source page.
Annual status reportsEach application's report clock, and a status table drafted row by row with original and current schedule, status and cited explanation.
DashboardOpen commitments, milestones met on time, what is due in 90 days, what is owed by kind and agency, and due dates ahead by product and quarter.
SettingsLead times, escalations, who signs and countersigns, routing rules and the rules that are locked.
Governance

Agency wording kept exactly, and two signatures to move a date

Every date cites its pageRequirements, commitments and promises link to the letter, minutes or response they came from, opened at the page with the agency's words and the date highlighted.
A named person signs each entryThe agents read and propose; the regulatory lead confirms and signs each register entry with the meaning of the signature, and the EU regulatory lead signs EU obligations.
Two signatures to move a dateA change to a date or scope carries a reason and two signatures (the regulatory lead signs, compliance countersigns), and the earlier version stays in the record.
The agency's wording, exactlyWording is copied as the agency wrote it, with no paraphrase. Titles can change; the wording does not, and each earlier version is kept.
Closed only on the agency's wordA commitment closes only when the agency confirms fulfillment. “Submitted” is not treated as done, or written as fulfilled in a status report.
Every step on the activity trailAgent steps, alerts, signatures and date changes are recorded with who, what and when. The register is a working tool; the registration system remains the system of record.
Configuration

Alert lead times and signers for each commitment, as settings

Alerts, who signs, how work is routed and which rules are locked are settings, on the audit trail.

SettingDefaultChoose from
Lead times90, 60, 30 and 7 days120 · 90 · 60 · 30 · 7 days, each on or off
Escalate to the regulatory leadOn — 30 days out with no draft or evidenceOn · Off
Weekly digest to ownersOn — Monday 08:00On · Off
New commitments from lettersRegulatory lead confirms and signsRegulatory lead · EU regulatory lead · Compliance · Regulatory operations
Changes to dates or scopeRegulatory lead + complianceRegulatory lead + compliance · Regulatory lead · EU regulatory lead · Compliance · Regulatory operations
EU obligations and renewalsEU regulatory leadEU regulatory lead · Regulatory lead · Compliance · Regulatory operations
Track promises in minutes and question responsesOnOn · Off
A commitment closes only when the agency confirms fulfillmentOn, lockedLocked on
Connections

Letters from the regulatory mailbox, minutes from the document repository

Regulatory mailboxapproval and supplement approval letters, read every 15 minutes
Registrations archive (RIM)correspondence and approvals, read nightly
Document repositoryFDA meeting minutes (Type A, B, C) and responses to agency questions
Affiliate uploadslocal approval certificates and conditions, with their translations
EU documentsAnnex II conditions, specific obligations, post-authorisation measures and CHMP outcomes
Status reportsannual status tables and 180-day progress reports, exported to Word
What it changes

Post-marketing commitment tracking results for operations and compliance

Each figure carries its label: a target the solution is built to, an estimate, a typical published result, or a proven one.

target
93%
of milestones met on time this year, every date watched daily
Met on time
of the milestones due this year
estimated
6h
to compile one annual status table, drafted and cited from the register
By hand≈ 38 h
With agents≈ 6 h
target
100%
of dates link to the letter or minutes page they came from
dates linked to their page

“demo” = seen in the working solution, on its sample data · “target” = the design goal, measured in the live solution · “estimated” = the working solution's own estimate before deployment. Regulations named as context: 21 CFR 314.81(b)(2)(vii) and 601.70 (annual status reports); FD&C Act 505(o)(3), 505B and 506B; EU post-authorisation measures. The company, products and documents in the worked example are sample data. Names on the screens are sample data.

Questions

PMR and PMC commitment tracking questions from regulatory teams

What is post-marketing commitment tracking?

Keeping every postmarketing requirement and commitment, EU obligation and local approval condition on record with its dates, owners and status until the agency confirms it is fulfilled. Post-Marketing Commitment Tracking does it with agents that read approval letters, minutes and question responses and put each item on one timeline by product, with the agency's exact words and the page.

How does it find promises made in meeting minutes?

The Promise Finder reads minutes and question responses, the discussion as well as the action items, for sentences such as “the sponsor agreed to” or “the company commits to”, and checks each against the timeline. It re-reads a product's file when a letter arrives or the product gets a new approval, and shows which promises are already on the timeline and which are not.

Does it track EU specific obligations and local conditions too?

Yes. The register holds US requirements and commitments, EU specific obligations, Annex II conditions and post-authorisation measures, and local conditions from agencies such as PMDA, Swissmedic, Health Canada, TGA, MHRA and ANVISA. The same study is linked across markets, and EU obligations are routed to the EU regulatory lead.

Can it draft the annual status report?

Yes. For each application the Status Reporter drafts the status of each postmarketing requirement and commitment (original and current schedule, the agency's status category and a short explanation with its evidence), due 60 days after the approval anniversary under 21 CFR 314.81(b)(2)(vii) and 601.70. It also drafts 180-day progress reports and EU obligation updates. Regulatory operations reviews and the regulatory lead signs.

How are owners alerted before a date is missed?

Each morning the Deadline Monitor checks all milestones and internal targets. Owners are alerted at 90, 60, 30 and 7 days by default, a slip is raised the day an internal target is missed, and the regulatory lead is told 30 days out when there is no draft or evidence.

Can an agent add, change or close a commitment on its own?

No. The agents propose; they do not add, change or close anything themselves. The regulatory lead signs each entry, compliance countersigns any change to a date or scope, and a commitment closes only when the agency confirms fulfillment.

Does it replace our RIM system?

No. It reads correspondence from your registrations archive and serves as the commitments register your team works in daily; the registration system remains the system of record.

What do we need to hand over to start tracking our commitments?

The Agentic Solution Engine builds and deploys it from your requirements and documents: your approval letters, minutes, responses and current commitments tracker. It goes live once all quality gates have passed, and we will walk you through it on your own correspondence first.

Try post-marketing commitment tracking
on your own letters and minutes.

We'll run Post-Marketing Commitment Tracking on a sample of your own approval letters, minutes and responses.